HY-2003 (10 mg/ml), BELKYRA and placebo
HY-2003-101
Phase 1 small_molecule active
Quick answer
HY-2003 (10 mg/ml), BELKYRA and placebo for Moderate or Severe Submental Fullness is a Phase 1 program (small_molecule) at The First People's Hospital of Lianyungang with 1 ClinicalTrials.gov record(s).
Program details
- Company
- The First People's Hospital of Lianyungang
- Indication
- Moderate or Severe Submental Fullness
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active